Keyword : targeted therapy
Zirabev as a representative of the largest family of biosimilars in oncology
Sorafenib in the treatment of iodine-negative differentiated thyroid cancerAuthors: Solodiannykova O.I. Kmetyuk Y.V. Stolyarova O.Yu. Danylenko V.V.... Т. 14, №2 (54)
Induction targeted therapy with tyrosine kinase inhibitors in the treatment of EGFR-positive non-small cell lung cancer. Clinical case and discussion of features of therapeutic «targeted» tumor pathomorphosisAuthors: Sukhoversha O.A. Tsyhankov K.V. Kuzhevskyi I.V. Koval S.S. Т. 13, № 2 (50)
Treatment of patients with Hodgkin’s lymphoma after progression: chemosensitivity, transplantation and targeted drugsAuthors: Rudiuk T. Novosad O. Kryachok I. Т. 12, № 1-2 (45-46)
The role of targeted therapy in the treatment of patients with EGFR+ mutations of lung cancer (review)Authors: Kolesnik O.P. Shevchenco A.I. Kadzhoian A.V. Kuzmenko V.A.... Т. 8, № 3 (31) 2018
Modern approaches to neoadjuvant therapy in patients with esophageal cancerAuthors: Kirkilevskyi S.I. Frydel R.I. Krahmalyov P.S. Kondratskyi Y. №3(19) 2015
Treatment of patients with advanced cutaneous melanoma: current approaches and perspectivesAuthors: Kukushkina M.M. Korovin S.I. Palivets A. Ostafiychuk V.V.... №4(16) 2014
Chemotherapy and targeted therapy combination in patients with platinum-resistant ovarian cancer: case reportAuthors: Kuznetsova O.V. Tchebotariova Rybin,G.M. Marzynkivska,A.I. N.V. Rybin A.I. №3(15) 2014
